A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. 1993

D Bilsland, and S A George, and N K Gibbs, and T Aitchison, and B E Johnson, and J Ferguson
Department of Photobiology, Ninewells Hospital and Medical School, Dundee, U.K.

Twenty-five patients suffering from severe polymorphic light eruption (PLE) were randomized to either photochemotherapy (PUVA) or narrow-band phototherapy (TL-01 UVB) treatment in early spring; patients receiving UVB were given placebo tablets to achieve a matching therapy procedure. During the 4 months following treatment, patient exposure to solar UVB was monitored with polysulphone badges. PLE occurrence, severity, and restriction of outdoor activity were recorded, using weekly diary-sheets. Analysis of covariance on this data, using the logarithm of UVB exposure as the explanatory variable, showed no significant differences between the treatments. TL-01 UVB is an effective alternative to PUVA in the management of PLE.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010787 Photosensitivity Disorders Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy. Actinic Reticuloid Syndrome,Dermatitis, Actinic,Photodermatitis,Chronic Actinic Dermatitis,Photosensitization,Actinic Dermatitides,Actinic Dermatitides, Chronic,Actinic Dermatitis,Actinic Dermatitis, Chronic,Actinic Reticuloid Syndromes,Chronic Actinic Dermatitides,Dermatitides, Actinic,Dermatitides, Chronic Actinic,Dermatitis, Chronic Actinic,Disorder, Photosensitivity,Disorders, Photosensitivity,Photodermatitides,Photosensitivity Disorder,Reticuloid Syndrome, Actinic,Reticuloid Syndromes, Actinic,Syndrome, Actinic Reticuloid,Syndromes, Actinic Reticuloid
D011701 PUVA Therapy Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA). Psoralen Ultraviolet A Therapy,Therapy, PUVA,PUVA Therapies,Therapies, PUVA
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012621 Seasons Divisions of the year according to some regularly recurrent phenomena usually astronomical or climatic. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Seasonal Variation,Season,Seasonal Variations,Variation, Seasonal,Variations, Seasonal
D014467 Ultraviolet Therapy The use of ultraviolet electromagnetic radiation in the treatment of disease, usually of the skin. This is the part of the sun's spectrum that causes sunburn and tanning. Ultraviolet A, used in PUVA, is closer to visible light and less damaging than Ultraviolet B, which is ionizing. Actinotherapy,Therapy, Ultraviolet,Actinotherapies,Therapies, Ultraviolet,Ultraviolet Therapies

Related Publications

D Bilsland, and S A George, and N K Gibbs, and T Aitchison, and B E Johnson, and J Ferguson
November 1999, Journal of the American Academy of Dermatology,
D Bilsland, and S A George, and N K Gibbs, and T Aitchison, and B E Johnson, and J Ferguson
June 2001, The Journal of dermatological treatment,
D Bilsland, and S A George, and N K Gibbs, and T Aitchison, and B E Johnson, and J Ferguson
April 1987, The British journal of dermatology,
D Bilsland, and S A George, and N K Gibbs, and T Aitchison, and B E Johnson, and J Ferguson
May 1998, Journal of the American Academy of Dermatology,
D Bilsland, and S A George, and N K Gibbs, and T Aitchison, and B E Johnson, and J Ferguson
January 1990, Acta dermato-venereologica,
D Bilsland, and S A George, and N K Gibbs, and T Aitchison, and B E Johnson, and J Ferguson
June 2001, The British journal of dermatology,
D Bilsland, and S A George, and N K Gibbs, and T Aitchison, and B E Johnson, and J Ferguson
January 2004, Clinical and experimental dermatology,
D Bilsland, and S A George, and N K Gibbs, and T Aitchison, and B E Johnson, and J Ferguson
August 1998, The Australasian journal of dermatology,
D Bilsland, and S A George, and N K Gibbs, and T Aitchison, and B E Johnson, and J Ferguson
October 2017, Actas dermo-sifiliograficas,
D Bilsland, and S A George, and N K Gibbs, and T Aitchison, and B E Johnson, and J Ferguson
June 1995, The British journal of dermatology,
Copied contents to your clipboard!